Maximum walking distance at 52 weeks was significantly improved with semaglutide. 2. There were fewer treatment-related serious adverse events in the semaglutide group compared to placebo. Evidence Ra ...

TrialGPT, developed by the National Institutes of Health, matches patients to clinical trials with 87.3 percent accuracy2.

In this Australian cohort of adults, individuals diagnosed with cancer experienced greater declines in physical functioning ...

Gepotidacin was non-inferior to ceftriaxone plus azithromycin for the primary outcome of microbiological success. 2. There were no serious or treatment-related adverse events in either group. Evidence ...

The HemoSphere Alta system from Becton Dickinson uses artificial intelligence to predict blood pressure drops during surgery2 ...

In this systematic review, strong evidence showed that unconditional cash transfers may increase breastfeeding in diverse ...

In this prospective cohort study, social isolation is associated with decreased survival time and accelerated onset of ...

TriNetX is using real world data to reduce clinical trial enrollment time by as much as 40 percent2. Artificial intelligence ...

The Food and Drug Administration is preparing to launch an agency wide generative artificial intelligence system by the end ...

Key predictors of chronic pain following motor vehicle collisions include elevated levels of acute post-traumatic stress ...

Low-frequency electrical stimulation yields greater stimulation efficiency than kilohertz-frequency stimulation in stroke ...

In this randomized clinical trial, exercise was significantly associated with improved sexual function in men with prostate ...